| 药品名称 | POTASSIUM CHLORIDE | | 申请号 | 019439 | 产品号 | 001 | | 活性成分 | POTASSIUM CHLORIDE | 市场状态 | 停止上市 | | 剂型或给药途径 | TABLET, EXTENDED RELEASE;ORAL | 规格 | 20MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | 治疗等效代码 | | 参比药物 | 否 | | 批准日期 | 1986/06/13 | 申请机构 | MERCK INC
| | 化学类型 | New dosage form | 审评分类 | Standard review drug |
|
|
| 与本品相关的专利信息（来自橙皮书Orange Book） | | 专利号 | 专利过期日 | 是否化合物专利 | 是否产品专利 | 专利用途代码 | 专利下载 | | 无 | | 历史专利信息 | | 4863743 | 2006/09/05 | | | U-99 | PDF格式 |
|
| 与本品相关的市场独占权保护信息 | | 独占权代码 | 失效日期 | | 无 | | 历史市场独占权保护信息 | | 无 |
|
| 与药品注册相关的信息 | | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | | 019439 | 022 | AP | Letter | 2008/06/16 | 下载 |
|
| 药品注册审批历史信息 | | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | | 019439 | 022 | AP | 2008/06/13 | Labeling Revision | | 019439 | 021 | AP | 2001/02/21 | Manufacturing Change or Addition | | 019439 | 020 | AP | 2000/09/01 | Manufacturing Change or Addition | | 019439 | 019 | AP | 1997/03/21 | Manufacturing Change or Addition | | 019439 | 018 | AP | 1996/11/15 | Manufacturing Change or Addition | | 019439 | 017 | AP | 1993/11/08 | Manufacturing Change or Addition | | 019439 | 015 | AP | 1990/12/20 | Labeling Revision | | 019439 | 014 | AP | 1989/08/08 | Labeling Revision | | 019439 | 012 | AP | 1989/03/15 | Control Supplement | | 019439 | 011 | AP | 1990/08/03 | Control Supplement | | 019439 | 010 | AP | 1989/04/04 | Manufacturing Change or Addition | | 019439 | 009 | AP | 1989/03/15 | Package Change | | 019439 | 008 | AP | 1988/10/26 | Manufacturing Change or Addition | | 019439 | 007 | AP | 1988/10/04 | Control Supplement | | 019439 | 005 | AP | 1988/06/02 | Manufacturing Change or Addition | | 019439 | 004 | AP | 1988/05/05 | Control Supplement | | 019439 | 003 | AP | 1988/08/23 | Labeling Revision | | 019439 | 002 | AP | 1987/08/12 | Labeling Revision | | 019439 | 001 | AP | 1988/08/23 | Labeling Revision | | 019439 | 000 | AP | 1986/06/13 | Approval |
|